Orexin/hypocretin was initially identified as a potential contributor to the hypertension in BPH/2 mice based on a study showing that BPH/2 mice have at least 2-fold higher hcrt mRNA in the hypothalamus than BPN/3 mice (Marques et al., 2011a). This evidence concerns the gene HCRT and hypertensive disorder.